Resmed Inc. buy Citigroup Inc.
Start price
18.09.25
/
50%
€229.80
Target price
18.09.26
€279.41
Performance (%)
-5.83%
Price
12:05
€216.40
Summary
This prediction is currently active. With a performance of -5.83%, the BUY prediction by Citigroup_Inc_ is trending in the wrong direction. This prediction currently runs until 18.09.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | -2.451% | -2.451% |
| iShares Core DAX® | 0.734% | 1.458% |
| iShares Nasdaq 100 | -2.686% | -0.146% |
| iShares Nikkei 225® | -2.261% | -2.729% |
| iShares S&P 500 | -1.346% | 0.467% |
Comments by Citigroup_Inc_ for this prediction
In the thread Resmed Inc. diskutieren
ResMed (NYSE:RMD) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $330.00 price target on the stock.
Ratings data for RMD provided by MarketBeat